01166cam2 22003011 450 SOBE0005560120170516141754.0887060356320170516d1995 |||||ita|0103 baitaIT<<Lo >>stato totalitariotesti di Valerio Castronovo, Renzo De Felice, Pietro Scoppolacapitoli fotografici a cura di Alberto Maria ArpinoRomaEditaliaIstituto Poligrafico e Zecca dello Stato1995174 p.ill.32 cm001SOB0047882001 <<L'>>Italia fascista, 1926-1939Castronovo, ValerioAF0000581307010077De_Felice, RenzoAF00003509070123070Scoppola, PietroAF00005154070139846Arpino, Alberto MariaAF00017181070ITUNISOB20170516RICAUNISOBUNISOB900|Sto86815SOBE00055601M 102 Monografia moderna SBNM900|Sto000037-3.1CON86815acquistoNmenleUNISOBUNISOB20170516140750.020170516140833.0menleStato totalitario1726224UNISOB03943nam 2200685Ia 450 991101950300332120200520144314.09786610721153978128072115112807211549780470029336047002933197804700293290470029323(CKB)1000000000357355(EBL)281583(SSID)ssj0000169749(PQKBManifestationID)11161703(PQKBTitleCode)TC0000169749(PQKBWorkID)10223443(PQKB)10226153(MiAaPQ)EBC281583(OCoLC)85821076(Perlego)2769316(EXLCZ)99100000000035735520050211d2006 uy 1engur|n|---|||||txtccrHeart failure molecules, mechanisms and therapeutic targetsChichester John Wiley20061 online resource (303 p.)Novartis Foundation symposium ;274Description based upon print version of record.9780470015971 0470015977 Includes bibliographical references and indexes.Cover; Contents; Introduction; Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation; DISCUSSION; A novel mechanism of mechanical stress-induced hypertrophy; DISCUSSION; Controlling cardiomyocyte survival; DISCUSSION; Mechanisms of angiotensin II-dependent progression to heart failure; DISCUSSION; Alterations in myocardial gene expression as a basis for cardiomyopathies and heart failure; DISCUSSION; Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy; DISCUSSIONRole of Akt in cardiac growth and metabolismDISCUSSION; Novel therapy for heart failure and exercise-induced ventricular tachycardia based on 'fixing' the leak in ryanodine receptors; DISCUSSION; GENERAL DISCUSSION I; Phospholamban as a therapeutic modality in heart failure; DISCUSSION; Sarcomere protein gene mutations and inherited heart disease: a b cardiac myosin heavy chain mutation causing endocardial fibroelastosis and heart failure; DISCUSSION; The cardiomyocyte cell cycle; DISCUSSION; Restoration of cardiac function with progenitor cells; DISCUSSIONSignalling pathways in cardiac regenerationDISCUSSION; Beyond small molecule drugs for heart failure: prospects for gene therapy; DISCUSSION; Dual roles of telomerase in cardiac protection and repair; DISCUSSION; Final general discussion; Closing remarks: historical perspective; Contributor index; Subject indexHeart failure is the main cause of death and disability in the industrialized world. There is a major need for novel therapeutics for prevention and reversal of cardiac pathology associated with heart failure and cardiac enlargement. Over recent years, dramatic progress has been made in unravelling the cellular circuitry involved in cardiac failure, as well as in normal cardiac growth, development and apoptosis. This work has revealed new and unexpected therapeutic targets in the heart. In addition, advances in understanding the role of stem cells in cardiac physiology have suggested strategieNovartis Foundation symposium ;274.Heart failureHeart failureTreatmentPathophysiologyHeartAdaptationHeart failure.Heart failureTreatmentPathophysiology.HeartAdaptation.616.129616.12906Novartis Foundation.MiAaPQMiAaPQMiAaPQBOOK9911019503003321Heart failure774825UNINA